FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224308954> ?p ?o ?g. }

• W4224308954 endingPage "53" @default.
• W4224308954 startingPage "35" @default.
• W4224308954 abstract "Background & AimsHyperbaric oxygen therapy (HBOT) is a promising treatment for moderate-to-severe ulcerative colitis. However, our current understanding of the host and microbial response to HBOT remains unclear. This study examined the molecular mechanisms underpinning HBOT using a multi-omic strategy.MethodsPre- and post-intervention mucosal biopsies, tissue, and fecal samples were collected from HBOT phase 2 clinical trials. Biopsies and fecal samples were subjected to shotgun metaproteomics, metabolomics, 16s rRNA sequencing, and metagenomics. Tissue was subjected to bulk RNA sequencing and digital spatial profiling (DSP) for single-cell RNA and protein analysis, and immunohistochemistry was performed. Fecal samples were also used for colonization experiments in IL10-/- germ-free UC mouse models.ResultsProteomics identified negative associations between HBOT response and neutrophil azurophilic granule abundance. DSP identified an HBOT-specific reduction of neutrophil STAT3, which was confirmed by immunohistochemistry. HBOT decreased microbial diversity with a proportional increase in Firmicutes and a secondary bile acid lithocholic acid. A major source of the reduction in diversity was the loss of mucus-adherent taxa, resulting in increased MUC2 levels post-HBOT. Targeted database searching revealed strain-level associations between Akkermansia muciniphila and HBOT response status. Colonization of IL10-/- with stool obtained from HBOT responders resulted in lower colitis activity compared with non-responders, with no differences in STAT3 expression, suggesting complementary but independent host and microbial responses.ConclusionsHBOT reduces host neutrophil STAT3 and azurophilic granule activity in UC patients and changes in microbial composition and metabolism in ways that improve colitis activity. Intestinal microbiota, especially strain level variations in A muciniphila, may contribute to HBOT non-response. Hyperbaric oxygen therapy (HBOT) is a promising treatment for moderate-to-severe ulcerative colitis. However, our current understanding of the host and microbial response to HBOT remains unclear. This study examined the molecular mechanisms underpinning HBOT using a multi-omic strategy. Pre- and post-intervention mucosal biopsies, tissue, and fecal samples were collected from HBOT phase 2 clinical trials. Biopsies and fecal samples were subjected to shotgun metaproteomics, metabolomics, 16s rRNA sequencing, and metagenomics. Tissue was subjected to bulk RNA sequencing and digital spatial profiling (DSP) for single-cell RNA and protein analysis, and immunohistochemistry was performed. Fecal samples were also used for colonization experiments in IL10-/- germ-free UC mouse models. Proteomics identified negative associations between HBOT response and neutrophil azurophilic granule abundance. DSP identified an HBOT-specific reduction of neutrophil STAT3, which was confirmed by immunohistochemistry. HBOT decreased microbial diversity with a proportional increase in Firmicutes and a secondary bile acid lithocholic acid. A major source of the reduction in diversity was the loss of mucus-adherent taxa, resulting in increased MUC2 levels post-HBOT. Targeted database searching revealed strain-level associations between Akkermansia muciniphila and HBOT response status. Colonization of IL10-/- with stool obtained from HBOT responders resulted in lower colitis activity compared with non-responders, with no differences in STAT3 expression, suggesting complementary but independent host and microbial responses. HBOT reduces host neutrophil STAT3 and azurophilic granule activity in UC patients and changes in microbial composition and metabolism in ways that improve colitis activity. Intestinal microbiota, especially strain level variations in A muciniphila, may contribute to HBOT non-response." @default.
• W4224308954 created "2022-04-26" @default.
• W4224308954 creator A5001118529 @default.
• W4224308954 creator A5004803970 @default.
• W4224308954 creator A5004879119 @default.
• W4224308954 creator A5009651541 @default.
• W4224308954 creator A5012998783 @default.
• W4224308954 creator A5013498569 @default.
• W4224308954 creator A5014597827 @default.
• W4224308954 creator A5015946021 @default.
• W4224308954 creator A5018718565 @default.
• W4224308954 creator A5021713245 @default.
• W4224308954 creator A5022634147 @default.
• W4224308954 creator A5024610010 @default.
• W4224308954 creator A5025171267 @default.
• W4224308954 creator A5027323292 @default.
• W4224308954 creator A5028862028 @default.
• W4224308954 creator A5031928314 @default.
• W4224308954 creator A5032648643 @default.
• W4224308954 creator A5033881627 @default.
• W4224308954 creator A5044573289 @default.
• W4224308954 creator A5047774923 @default.
• W4224308954 creator A5050379324 @default.
• W4224308954 creator A5051587245 @default.
• W4224308954 creator A5054422497 @default.
• W4224308954 creator A5058181019 @default.
• W4224308954 creator A5070196553 @default.
• W4224308954 creator A5073181553 @default.
• W4224308954 creator A5077137639 @default.
• W4224308954 creator A5082310752 @default.
• W4224308954 creator A5082559708 @default.
• W4224308954 creator A5082564115 @default.
• W4224308954 creator A5082720301 @default.
• W4224308954 creator A5086305028 @default.
• W4224308954 creator A5087387855 @default.
• W4224308954 creator A5088047102 @default.
• W4224308954 creator A5089772765 @default.
• W4224308954 creator A5091551190 @default.
• W4224308954 date "2022-01-01" @default.
• W4224308954 modified "2023-10-16" @default.
• W4224308954 title "The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients" @default.
• W4224308954 cites W1986081926 @default.
• W4224308954 cites W1990746640 @default.
• W4224308954 cites W2008882251 @default.
• W4224308954 cites W2039014923 @default.
• W4224308954 cites W2052570167 @default.
• W4224308954 cites W2055780184 @default.
• W4224308954 cites W2065289753 @default.
• W4224308954 cites W2075325752 @default.
• W4224308954 cites W2078703212 @default.
• W4224308954 cites W2078730804 @default.
• W4224308954 cites W2096204372 @default.
• W4224308954 cites W2138765945 @default.
• W4224308954 cites W2139738983 @default.
• W4224308954 cites W2149423038 @default.
• W4224308954 cites W2156383978 @default.
• W4224308954 cites W2162133321 @default.
• W4224308954 cites W2303711004 @default.
• W4224308954 cites W2508850208 @default.
• W4224308954 cites W2522926417 @default.
• W4224308954 cites W2562786167 @default.
• W4224308954 cites W2609398719 @default.
• W4224308954 cites W2736768390 @default.
• W4224308954 cites W2755782141 @default.
• W4224308954 cites W2772791758 @default.
• W4224308954 cites W2793920655 @default.
• W4224308954 cites W2794407684 @default.
• W4224308954 cites W2885074747 @default.
• W4224308954 cites W2889444842 @default.
• W4224308954 cites W2889551008 @default.
• W4224308954 cites W2902287405 @default.
• W4224308954 cites W2924306602 @default.
• W4224308954 cites W2924880215 @default.
• W4224308954 cites W2949775839 @default.
• W4224308954 cites W2952591889 @default.
• W4224308954 cites W2977901918 @default.
• W4224308954 cites W2982535496 @default.
• W4224308954 cites W2989725069 @default.
• W4224308954 cites W3001344052 @default.
• W4224308954 cites W3005787056 @default.
• W4224308954 cites W3007555042 @default.
• W4224308954 cites W3012943203 @default.
• W4224308954 cites W3047574113 @default.
• W4224308954 cites W3107258902 @default.
• W4224308954 cites W3149342847 @default.
• W4224308954 cites W3161582077 @default.
• W4224308954 cites W3188537711 @default.
• W4224308954 cites W3209464029 @default.
• W4224308954 cites W4206199829 @default.
• W4224308954 cites W986067203 @default.
• W4224308954 doi "https://doi.org/10.1016/j.jcmgh.2022.03.008" @default.
• W4224308954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35378331" @default.
• W4224308954 hasPublicationYear "2022" @default.
• W4224308954 type Work @default.
• W4224308954 citedByCount "4" @default.
• W4224308954 countsByYear W42243089542022 @default.
• W4224308954 countsByYear W42243089542023 @default.
• W4224308954 crossrefType "journal-article" @default.

• next